Health Condition 1: O630- Prolonged first stage (of labor)
Conditions
Interventions
Intervention1: Injection. Hyoscine n Butyl Bromide: The patients would be administered single dose of 20 mg of Hyoscine N Butyl Bromide (1 ml of HNBB, diluted in 9 ml of saline solution) intravenously
Sponsors
Dr Arularasan J
Eligibility
Inclusion criteria
Inclusion criteria: - Primigravida and Multigravida - Gestational age of 37 completed weeks to 41 weeks - Live singleton pregnancy - Cephalic presentation - In active phase of labour - Membranes intact or ruptured ( PROM <12 hours)
Exclusion criteria
Exclusion criteria: - Patients having contraindications for usage of HNBB such as Myasthenia Gravis, Narrow angle glaucoma - Multiple pregnancies - conditions where there are Previous Uterine scars - Malpresentation - Cephalo pelvic dispropotion - Antepartum hemorrhage - Medical disorders complicating pregnancies such as severe anemia, cardiac diseases, hypertensive disorders -
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Improved degree of pain relief experienced by the parturient during labourTimepoint: Immediate- 4 hours;lesser percentage of women deliver by caesarian sectionTimepoint: Immediate to 8 hours | — |
Primary
| Measure | Time frame |
|---|---|
| - Reduction in the duration of LabourTimepoint: immediate - 8 hours | — |
Countries
India
Contacts
Public ContactArularasan J
Indira Gandhi Medical College and Research Institute , Puducherry
Outcome results
None listed